The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,738
Structure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794 · cited 1×
“Telomerase activity is dramatically elevated in most tumors of murine and human origi”
BackgroundProliferating dendritic cell progenitors in human blood.
Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., & Schuler, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.83 · Cited by 1,840
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Introduction of soluble protein into the class I pathway of antigen processing and presentation
Moore, M. W., Carbone, F. R., & Bevan, M. J. (1988) · Cell · doi:10.1016/s0092-8674(88)91043-4 · Cited by 1,092
Greider, C. W. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.002005 · Cited by 1,021
IMMUNODOMINANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I–RESTRICTED T LYMPHOCYTE RESPONSES
Yewdell, J. W., & Bennink, J. R. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.51 · Cited by 944
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
Boczkowski, D., Nair, S. K., Snyder, D., & Gilboa, E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.465 · Cited by 915
Self-citationActivation of telomerase in human lymphocytes and hematopoietic progenitor cells
Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., & Yamakido, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3711 · Cited by 853 · cited 1×
“Telomerase activity is, however, present in proliferating tissues such as activated T and B cells, hematopoietic progenitors, germ cells and cells within intestinal and liver tissu”
BackgroundHuman tumor antigens recognized by T lymphocytes.
Boon, T., & van der Bruggen, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.725 · Cited by 842
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
Garrido, F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M., & Stern, P. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(96)10075-x · Cited by 770
Developmental and tissue-specific regulation of mouse telomerase and telomere length.
Prowse, K. R., & Greider, C. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4818 · Cited by 690
Kilian, A., Bowtell, D. D. L., Abud, H. E., Hime, G. R., Venter, D. J., Keese, P. K., Duncan, E. L., Reddel, R. R., & Jefferson, R. A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2011 · Cited by 585
Vonderheide, R. H., Hahn, W. C., Schultze, J. L., & Nadler, L. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80066-7 · Cited by 570
A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens
Rosenberg, S. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80028-x · Cited by 566
Ashley, D. M., Faiola, B., Nair, S., Hale, L. P., Bigner, D. D., & Gilboa, E. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1177 · Cited by 439
Self-citationNair, S. K., Boczkowski, D., Morse, M., Cumming, R. I., Lyerly, H. K., & Gilboa, E. (1998) · Nature Biotechnology · doi:10.1038/nbt0498-364 · Cited by 398
Self-citationPiatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright, W. E., & Shay, J. W. (1995) · Methods in Cell Science · doi:10.1007/bf00981880 · Cited by 384
The Makings of a Tumor Rejection Antigen
Gilboa, E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80101-6 · Cited by 381
Self-citationHLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
Hicklin, D. J., Marincola, F. M., & Ferrone, S. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01451-3 · Cited by 376
Greenberg, R. A., Allsopp, R. C., Chin, L., Morin, G. B., & DePinho, R. A. (1998) · Oncogene · doi:10.1038/sj.onc.1201933 · Cited by 338
Boczkowski, D., Nair, S. K., Nam, J., Lyerly, H. K., & Gilboa, E. (2000) · PubMed · Cited by 313
Self-citationYewdell, J. W., Norbury, C. C., & Bennink, J. R. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60785-3 · Cited by 284
Responsiveness to HY Antigen Ir Gene Complementation and Target Cell Specificity
Simpson, E., & Gordon, R. D. (1977) · Immunological Reviews · doi:10.1111/j.1600-065x.1977.tb00235.x · Cited by 214
Nair, S. K., Hull, S., Coleman, D., Gilboa, E., Lyerly, H. K., & Morse, M. A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990702)82:1<121::aid-ijc20>3.0.co;2-x · Cited by 174
Self-citationRegulation of Telomere Length and Telomerase in T and B Cells
Weng, N., Hathcock, K. S., & Hodes, R. J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80597-x · Cited by 159
Expression profile of the putative catalytic subunit of the telomerase gene.
Ramakrishnan, S., Eppenberger, U., Mueller, H., Shinkai, Y., & Narayanan, R. (1998) · PubMed · Cited by 150
Fu, T., Friedman, A., Ulmer, J. B., Liu, M. A., & Donnelly, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2715-2721.1997 · Cited by 130
Telomere Length, Aging, and Somatic Cell Turnover
Hodes, R. J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.153 · Cited by 108
Johnston, J. V., Malacko, A. R., Mizuno, M. T., McGowan, P., Hellström, I., Hellström, K. E., Marquardt, H., & Chen, L. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.791 · Cited by 96
Protection against lethal viral infection by vaccination with nonimmunodominant peptides
Oukka, M., Manuguerra, J., Livaditis, N., Tourdot, S., le Riche, N., Vergnon, I., Cordopatis, P., & Kosmatopoulos, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.7.3039 · Cited by 81
Porgador, A., Feldman, M., & Eisenbach, L. (1989) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.1989.tb00475.x · Cited by 64
A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity
Volgmann, T., Klein-Struckmeier, A., & Mohr, H. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90379-7 · Cited by 60
Do human cancers express sharedprotectiveantigens? or The necessity of remembrance of things past
Srivastava, P. K. (1996) · Seminars in Immunology · doi:10.1006/smim.1996.0038 · Cited by 60
Waes, C. V., Monach, P. A., Urban, J. L., Wortzel, R. D., & Schreiber, H. W. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02575.x · Cited by 35
Coveney, E. C., Clary, B. M., Iacobucci, M., Philip, R., & Lyerly, H. K. (1996) · Surgery · doi:10.1016/s0039-6060(96)80297-2 · Cited by 22
Cited by
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
Antigen Presentation and T Cell Stimulation by Dendritic Cells
Guermonprez, P., Valladeau, J., Zitvogel, L., Théry, C., & Amigorena, S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064828 · Cited by 1,926
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062
Malignant effusions and immunogenic tumour-derived exosomes
Andre, F., Schartz, N. E., Movassagh, M., Flament, C., Pautier, P., Morice, P., Pomel, C., Lhomme, C., Escudier, B., Le Chevalier, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09552-1 · Cited by 953
Aptamers: An Emerging Class of Therapeutics
Nimjee, S. M., Rusconi, C. P., & Sullenger, B. A. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144915 · Cited by 937
Metadata
- Authors
- Nair, S. K., Heiser, A., Boczkowski, D., Majumdar, A., Naoe, M., Lebkowski, J. S., Vieweg, J., & Gilboa, E.
- Venue
- Nature Medicine
- Published
- 2000-09
- Volume
- 6
- Issue
- 9
- Pages
- 1011-1017
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1489870404
- Cited by
- 348
- References
- 38
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.